ArticleInternational journal of hematology2018

Dasatinib-induced anti-leukemia cellular immunity through a novel subset of CD57 positive helper/cytotoxic CD4 T cells in chronic myelogenous leukemia patients.

Naoki Watanabe et al.PubMed ↗Publisher ↗

No numbers read from the abstract.